Organovo Holdings, Inc. is an early commercial-stage company focused on developing and commercializing functional human tissues. The Company focuses on the generation of three-dimensional (3D) human tissues, by utilizing its platform technology to create human tissue constructs in 3D. It is focused on development of products, including 3D human tissues used for the preclinical assessment of drug effects, including applications in predictive toxicology, absorption, distribution, metabolism, excretion (ADME), and drug metabolism and pharmacokinetics (DMPK); customized human tissues as living, dynamic models of human biology or disease, for use in drug discovery and development, and three-dimensional human tissues for clinical applications, such as blood vessels for bypass grafting, nerve grafts for nerve damage repair and functional tissue patches for the repair or replacement of damaged tissues and organs.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Biotechnology & Medical Research - NEC
- Sub-Industry: N/A
- Symbol: NASDAQ:ONVO
- CUSIP: N/A
- Web: www.organovo.com
Average Prices:- 50 Day Moving Avg: $2.68
- 200 Day Moving Avg: $3.01
- 52 Week Range: $2.30 - $4.99
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -6.97
- P/E Growth: 0.00
Profitability:- Net Margins: -908.91%
- Return on Equity: -63.92%
- Return on Assets: -58.77%
Debt:- Current Ratio: 10.83%
- Quick Ratio: 10.74%
Misc:- Average Volume: 824,894 shs.
- Beta: 2.99
Frequently Asked Questions for Organovo Holdings (NASDAQ:ONVO)
What is Organovo Holdings' stock symbol?
Organovo Holdings trades on the NASDAQ under the ticker symbol "ONVO."
How were Organovo Holdings' earnings last quarter?
Organovo Holdings, Inc. (NASDAQ:ONVO) announced its earnings results on Wednesday, June, 7th. The company reported ($0.10) earnings per share for the quarter, topping the consensus estimate of ($0.11) by $0.01. The firm had revenue of $0.80 million for the quarter, compared to the consensus estimate of $0.76 million. Organovo Holdings had a negative net margin of 908.91% and a negative return on equity of 63.92%. The firm's revenue was up 700.0% on a year-over-year basis. View Organovo Holdings' Earnings History.
Where is Organovo Holdings' stock going? Where will Organovo Holdings' stock price be in 2017?
4 analysts have issued 1 year price objectives for Organovo Holdings' stock. Their forecasts range from $3.75 to $15.00. On average, they anticipate Organovo Holdings' share price to reach $6.94 in the next year. View Analyst Ratings for Organovo Holdings.
Who are some of Organovo Holdings' key competitors?
Some companies that are related to Organovo Holdings include Agenus (AGEN), Cara Therapeutics (CARA), Inovio Pharmaceuticals (INO), AC Immune SA (ACIU), Novavax (NVAX), Adamas Pharmaceuticals (ADMS), Abeona Therapeutics (ABEO), PDL BioPharma (PDLI), Celyad SA (CYAD), Concert Pharmaceuticals (CNCE), Celldex Therapeutics (CLDX), Puretech Health PLC (PRTC), Curis (CRIS), Nabriva Therapeutics AG (NBRV), Idera Pharmaceuticals (IDRA), Advaxis (ADXS), Codexis (CDXS) and Voyager Therapeutics (VYGR).
Who are Organovo Holdings' key executives?
Organovo Holdings' management team includes the folowing people:
- Keith E. Murphy, Chairman of the Board
- Taylor J. Crouch, President, Chief Executive Officer
- Eric Michael David M.D. J.D., Executive Vice President - Pre-Clinical Development, Chief Strategy Officer
- Sharon Collins Presnell Ph.D., Chief Scientific Officer
- Jennifer Kinsbruner Bush J.D., Compliance Officer, General Counsel, Corporate Secretary
- Paul Gallant, General Manager
- Robert F. Baltera Jr., Lead Independent Director
- James T. Glover, Independent Director
- Richard A. Heyman Ph.D., Independent Director
- Tamar D. Howson, Independent Director
Who owns Organovo Holdings stock?
Organovo Holdings' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Quotient Investors LLC (0.00%). Company insiders that own Organovo Holdings stock include Eric David and Keith Murphy. View Institutional Ownership Trends for Organovo Holdings.
How do I buy Organovo Holdings stock?
Shares of Organovo Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Organovo Holdings' stock price today?
One share of Organovo Holdings stock can currently be purchased for approximately $2.37.
MarketBeat Community Rating for Organovo Holdings (NASDAQ ONVO)MarketBeat's community ratings are surveys of what our community members think about Organovo Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Organovo Holdings (NASDAQ:ONVO) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 4 Buy Ratings |
| Consensus Rating: | Buy (Score: 3.00) |
| Consensus Price Target: | $6.94 (192.72% upside) |
Analysts' Ratings History for Organovo Holdings (NASDAQ:ONVO)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 6/9/2017 | Evercore ISI | Reiterated Rating | Outperform | $4.00 -> $3.75 | Low |  |
| 6/8/2017 | Jefferies Group LLC | Reiterated Rating | Buy | $4.50 -> $4.00 | Medium | |
| 1/25/2017 | Raymond James Financial, Inc. | Initiated Coverage | Outperform | $5.00 | N/A | |
| 12/15/2016 | BTIG Research | Initiated Coverage | Buy | $15.00 | N/A | |
(Data available from 7/24/2015 forward)
Earnings History for Organovo Holdings (NASDAQ:ONVO)Earnings History by Quarter for Organovo Holdings (NASDAQ ONVO)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 6/7/2017 | Q4 2017 | ($0.11) | ($0.10) | $0.76 million | $0.80 million | View | Listen | |
| 2/9/2017 | Q3 2017 | ($0.10) | ($0.09) | $1.40 million | $1.15 million | View | Listen | |
| 11/3/2016 | Q217 | ($0.11) | ($0.10) | $0.50 million | $1.38 million | View | Listen | |
| 8/4/2016 | Q1 | ($0.10) | ($0.09) | $0.30 million | $0.89 million | View | Listen | |
| 6/9/2016 | Q4 | ($0.11) | ($0.09) | $0.10 million | $0.55 million | View | Listen | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Organovo Holdings (NASDAQ:ONVO)2019 EPS Consensus Estimate: ($0.32)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2019 | 1 | ($0.08) | ($0.08) | ($0.08) |
| Q2 2019 | 1 | ($0.08) | ($0.08) | ($0.08) |
| Q3 2019 | 1 | ($0.08) | ($0.08) | ($0.08) |
| Q4 2019 | 1 | ($0.08) | ($0.08) | ($0.08) |
(Data provided by Zacks Investment Research)
Dividend History for Organovo Holdings (NASDAQ:ONVO)
No dividend announcements for this company have been tracked by MarketBeat.com
Headline Trends for Organovo Holdings (NASDAQ:ONVO)
Latest Headlines for Organovo Holdings (NASDAQ:ONVO)
| Source: |
|
| Date | Headline |
|---|
 | $880,000.00 in Sales Expected for Organovo Holdings, Inc. (NASDAQ:ONVO) This Quarter
www.americanbankingnews.com - July 20 at 11:44 AM |
 | Organovo Announces Release Date for Fiscal First-Quarter 2018 Financial Results
finance.yahoo.com - July 19 at 12:55 AM |
 | How Risky Is Organovo Holdings, Inc.?
www.fool.com - July 18 at 4:13 PM |
 | Organovo - Going The Right Direction - Seeking Alpha
seekingalpha.com - July 15 at 7:12 AM |
| ETFs with exposure to Organovo Holdings, Inc. : July 13, 2017
finance.yahoo.com - July 14 at 7:09 AM |
| Zacks: Brokerages Set $4.50 Target Price for Organovo Holdings, Inc. (NASDAQ:ONVO)
www.americanbankingnews.com - July 12 at 8:34 AM |
| Here's Why Organovo Holdings Inc Fell 10.5% in June
finance.yahoo.com - July 11 at 6:24 AM |
| ETFs with exposure to Organovo Holdings, Inc. : July 3, 2017
finance.yahoo.com - July 4 at 2:59 AM |
| Zacks: Organovo Holdings, Inc. (ONVO) Given $4.50 Average Target Price by Analysts
www.americanbankingnews.com - June 27 at 10:10 AM |
| $880,000.00 in Sales Expected for Organovo Holdings, Inc. (ONVO) This Quarter
www.americanbankingnews.com - June 24 at 9:30 AM |
| Featured Company News - Pamplona to Acquire PAREXEL; Another Contract Researcher Goes Private
finance.yahoo.com - June 23 at 8:47 AM |
| ETFs with exposure to Organovo Holdings, Inc. : June 22, 2017
finance.yahoo.com - June 23 at 8:47 AM |
| 3 Reasons Organovo Holdings, Inc. Stock Could Fall Even More
www.fool.com - June 22 at 4:32 PM |
| Brokerages Anticipate Organovo Holdings, Inc. (ONVO) Will Announce Earnings of -$0.10 Per Share
www.americanbankingnews.com - June 22 at 12:23 PM |
| Zacks: Brokerages Set $4.50 Price Target for Organovo Holdings, Inc. (ONVO)
www.americanbankingnews.com - June 15 at 2:52 PM |
| ETFs with exposure to Organovo Holdings, Inc. : June 12, 2017
finance.yahoo.com - June 12 at 6:44 PM |
| Analysts Offer Predictions for Organovo Holdings, Inc.'s FY2019 Earnings (ONVO)
www.americanbankingnews.com - June 12 at 9:50 AM |
| Organovo Holdings, Inc. :ONVO-US: Earnings Analysis: 2017 By the Numbers : June 9, 2017
finance.yahoo.com - June 9 at 7:15 PM |
| Organovo Holdings' (ONVO) "Outperform" Rating Reiterated at Evercore ISI
www.americanbankingnews.com - June 9 at 6:58 PM |
| Organovo Holdings Inc to Post Q1 2019 Earnings of ($0.08) Per Share, Jefferies Group Forecasts (ONVO)
www.americanbankingnews.com - June 9 at 2:20 PM |
| Organovo Holdings Inc (ONVO) Stock Rating Reaffirmed by Jefferies Group LLC
www.americanbankingnews.com - June 8 at 9:10 PM |
| Edited Transcript of ONVO earnings conference call or presentation 7-Jun-17 9:00pm GMT
finance.yahoo.com - June 8 at 9:31 AM |
| Organovo Holdings Still Not Back on Track
finance.yahoo.com - June 8 at 9:31 AM |
| Organovo Holdings Inc (ONVO) Announces Quarterly Earnings Results
www.americanbankingnews.com - June 8 at 8:14 AM |
 | Organovo to Present at Jefferies Healthcare Conference - GlobeNewswire (press release)
www.globenewswire.com - June 5 at 7:39 PM |
| Analysts Expect Organovo Holdings Inc (ONVO) Will Announce Quarterly Sales of $630,000.00
www.americanbankingnews.com - May 31 at 2:48 PM |
| Organovo Holdings, Inc. breached its 50 day moving average in a Bullish Manner : ONVO-US : May 29, 2017
finance.yahoo.com - May 29 at 8:34 AM |
| Organovo Holdings Inc (ONVO) Expected to Announce Earnings of -$0.11 Per Share
www.americanbankingnews.com - May 29 at 8:22 AM |
| Analysts Anticipate Organovo Holdings Inc (ONVO) to Post ($0.11) Earnings Per Share
www.americanbankingnews.com - May 26 at 2:30 PM |
| Organovo Presents New Preclinical Data on 3D Bioprinted Human Liver Tissues at World Advanced Therapies and Regenerative Medicine Congress
finance.yahoo.com - May 19 at 11:49 AM |
| Organovo Announces Release Date for Fiscal Fourth-Quarter 2017 Financial Results
finance.yahoo.com - May 17 at 8:45 AM |
| Organovo Holdings, Inc. breached its 50 day moving average in a Bullish Manner : ONVO-US : May 17, 2017
finance.yahoo.com - May 17 at 8:45 AM |
| Here's Why Organovo Holdings Stock Fell 5.2% In April
finance.yahoo.com - May 11 at 9:03 AM |
 | Research Reports Initiation on Medical Labs Stocks -- Organovo, DexCom, Quest ...
www.prnewswire.com - May 9 at 11:17 AM |
| $630,000.00 in Sales Expected for Organovo Holdings Inc (ONVO) This Quarter
www.americanbankingnews.com - May 5 at 1:38 PM |
| Organovo Holdings Inc (ONVO) Given Consensus Rating of "Strong Buy" by Brokerages
www.americanbankingnews.com - May 4 at 9:16 AM |
| Organovo Holdings (ONVO) Receives Daily Media Impact Rating of 0.15
www.americanbankingnews.com - May 4 at 12:40 AM |
| -$0.11 EPS Expected for Organovo Holdings Inc (ONVO) This Quarter
www.americanbankingnews.com - May 3 at 8:24 PM |
| Organovo Holdings, Inc. – Value Analysis (NASDAQ:ONVO) : May 3, 2017
finance.yahoo.com - May 3 at 8:00 PM |
| Somewhat Positive Press Coverage Unlikely to Impact Organovo Holdings (ONVO) Share Price
www.americanbankingnews.com - April 30 at 3:26 PM |
| Favorable Press Coverage Likely to Impact Organovo Holdings (ONVO) Stock Price
www.americanbankingnews.com - April 28 at 12:36 AM |
 | Clearside Biomedical, Inc. Announces Completion Of Patient Enrollment In Phase 1/2 Open Label Clinical Trial Of CLS-TA In Diabetic Macular Edema
www.thestreet.com - April 20 at 9:07 AM |
| Organovo Holdings (ONVO) Given Daily News Impact Score of -0.29
www.americanbankingnews.com - April 19 at 11:54 AM |
| Organovo Holdings Inc (ONVO) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - April 18 at 7:54 AM |
| Brokerages Expect Organovo Holdings Inc (ONVO) to Post ($0.11) EPS
www.americanbankingnews.com - April 17 at 6:37 PM |
| Organovo Holdings (ONVO) Given Daily Media Sentiment Score of 0.44
www.americanbankingnews.com - April 15 at 10:07 AM |
| Organovo Holdings Inc (ONVO) Upgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - April 14 at 10:06 AM |
| Organovo Holdings CEO Leaves: Should Investors Be Worried? - Motley Fool
www.fool.com - April 14 at 8:03 AM |
| What's Next for Organovo Holdings Inc.? - Motley Fool
www.fool.com - April 12 at 7:59 PM |
| Organovo Holdings Inc (ONVO) Short Interest Down 4.3% in March
www.americanbankingnews.com - April 12 at 4:22 PM |
Organovo Holdings (ONVO) Chart for Monday, July, 24, 2017
